Examination Report |
1 | Power of Attorney | 03 Sep 2012 |
2 | Reply to Exam Report (MIS-R) | 28 Aug 2013 |
3 | Journal Copy | 07 Aug 2017 |
4 | Journal Copy | 07 Aug 2017 |
5 | Certificate | 31 Dec 2017 |
6 | TM-R(RENEWAL OF TRADE MARK) | 25 Aug 2022 |
1 | Hearing Notice (Show Cause) | 2970329 | 1536022 | 02 Feb 2016 |
2 | Hearing Notice (Adjourned) | 4828237 | 2088062 | 13 Jun 2017 |
3 | Tribunal ABA Notice for : 2388496 | 4965839 | 2165866 | 25 Jul 2017 |
4 | O3 NOTICE | 13517166 | 5616228 | 20 May 2022 |
5 | RENEWAL INTIMATION LETTER | 14000655 | 28 Aug 2022 |
Trademark was applied on 03 September 2012 with IP India.
Proprietor of Xplode sf is EMCURE PHARMACEUTICALS.
Class(es) in which the trademark was applied to is 5.
Status of Xplode sf is Registered.
Application number alloted to the trademark is 2388496.
Aditya & Associates is the Trademark agent/attorney.
Trademark has been filed in the following category:
WORD